Results 61 to 70 of about 3,757,704 (310)

Incidence of adverse perinatal outcomes and risk factors among women with pre-eclampsia, southern Ethiopia: a prospective open cohort study

BMJ Paediatrics Open, 2022
Background In Ethiopia, in 2021, more than 80% of all newborn deaths were caused by preventable and treatable conditions. This study aimed to measure the incidence of adverse perinatal outcomes and risk factors among women with pre-eclampsia in the ...
Kassahun Alemu Gelaye, Telake Azale, Birhanu Jikamo, Mulat Adefris   +3 more
doaj   +1 more source

Translating research into policy and practice in developing countries: a case study of magnesium sulphate for pre-eclampsia. [PDF]

, 2005
BACKGROUND: The evidence base for improving reproductive health continues to grow. However, concerns remain that the translation of this evidence into appropriate policies is partial and slow.
Lewin, Simon, Duley, Lelia, Trommald, Mari, Oxman, Andrew David, Trommald Mari, Duley Lelia, Lewin Simon, Innvaer Simon, Dahlgren Astrid T, Paulsen, Elizabeth J, Aaserud Morten, Innvaer, Simon, Zwarenstein Merrick, Aaserud, Morten, Dahlgren, Astrid T, Oxman Andrew D, Zwarenstein, Merrick, Oxman, Andrew D, Paulsen Elizabeth J   +18 more
core   +1 more source

Risk factors for pre‐eclampsia: Received wisdom versus reality

, 2022
Screening for pre-eclampsia is not new, and in fact formed the original rationale for the introduction of antenatal care. Over time, it has become apparent that establishing a patient's risk for pre-eclampsia early in gestation is beneficial ...
Da Silva Costa, Fabricio, Stefan C. Kane, Kane, Stefan C, Fabricio Da Silva Costa   +3 more
core   +1 more source

Is Pre-eclampsia Preventable?

Annals of Medicine, 1991
Pre-eclampsia is characterised by reduced utero-placental blood flow which in turn results from vascular damage occurring early in pregnancy. Endothelial damage and reduced prostacyclin and nitric oxide synthesis will initiate excessive platelet aggregation, fibrin deposition and vascular occlusion. Prevention of pre-eclampsia is dependent on affecting
openaire   +2 more sources

Does induction or augmentation of labor increase the risk of postpartum hemorrhage in pregnant women with anemia? A multicenter prospective cohort study in India

International Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 299-309, April 2025.
Abstract Objective To investigate whether induction/augmentation of labor in pregnant women with anemia increases the risk of postpartum hemorrhage (PPH) and whether this risk varied by indications for labor induction/augmentation and by anemia severity in pregnancy.
Tuck Seng Cheng, Farzana Zahir, Carolin Solomi V, Ashok Verma, Sereesha Rao, Saswati Sanyal Choudhury, Gitanjali Deka, Pranabika Mahanta, Swapna Kakoty, Robin Medhi, Shakuntala Chhabra, Anjali Rani, Amrit Bora, Indrani Roy, Bina Minz, Omesh Kumar Bharti, Rupanjali Deka, Charles Opondo, David Churchill, Marian Knight, Jennifer J. Kurinczuk, Manisha Nair   +21 more
wiley   +1 more source

Cost‐effectiveness of a randomized controlled trial comparing low‐dose aspirin to placebo for the prevention of recurrent preterm birth

International Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 399-407, April 2025.
Abstract To assess the cost‐effectiveness of low‐dose aspirin compared to placebo for the prevention of recurrent preterm birth from a healthcare perspective. This was a cost‐effectiveness analysis alongside a multicenter, randomized, double‐blinded, placebo‐controlled trial.
Anadeijda J. E. M. C. Landman, Hana M. Broulikova, Laura Visser, Tobias A. J. Nijman, Marieke A. C. Hemels, Karin C. Vollebregt, Elisabeth M. A. Boormans, Henk A. Bremer, Esther Tuinman, Josje Langenveld, Flip van der Made, Robbert J. P. Rijnders, Huib A. A. M. van Vliet, Liv M. Freeman, Roel de Heus, Judith Blaauw, Ineke Krabbendam, Rafli van de Laar, Marieke F. G. Verberg, Hubertina C. J. Scheepers, Ben W. Mol, Christianne J. M. de Groot, Martijn A. Oudijk, Judith E. Bosmans, Marjon A. de Boer   +24 more
wiley   +1 more source

Association of serum homocysteine with vitamin B12 and folate levels in women with pre-eclampsia in a tertiary health care center in Nepal

BMC Women's Health
Background Pre-eclampsia is a syndrome that chiefly includes the development of new-onset hypertension and proteinuria after 20 weeks of pregnancy. Pre-eclampsia is one of the major causes of mortality and morbidity in Nepal.
Binod Kumar Yadav, Suvana Maskey, Aseem Bhattarai, Salina Pradhananga, Sabina Shakya, Astha Regmi   +5 more
doaj   +1 more source

Prediction of pre-eclampsia and its subtypes in high-risk cohort: hyperglycosylated human chorionic gonadotropin in multivariate models

BMC Pregnancy and Childbirth, 2018
Background The proportion of hyperglycosylated human chorionic gonadotropin (hCG-h) to total human chorionic gonadotropin (%hCG-h) during the first trimester is a promising biomarker for prediction of early-onset pre-eclampsia.
Katja Murtoniemi, Pia M. Villa, Jaakko Matomäki, Elina Keikkala, Piia Vuorela, Esa Hämäläinen, Eero Kajantie, Anu-Katriina Pesonen, Katri Räikkönen, Pekka Taipale, Ulf-Håkan Stenman, Hannele Laivuori   +11 more
doaj   +1 more source

Diagnosis and management of pre-eclampsia: an update

, 2010
Judi A TurnerDepartment of Anesthesiology, David Geffen School of Medicine, University of California, Los Angeles, CA, USAAbstract: Pre-eclampsia is a significant, multifactorial, multiorgan disease affecting 5%–8% of all pregnancies in the US ...
Judi A Turner, Judi Turner
core   +1 more source

Inflammation and pre-eclampsia

Seminars in Fetal and Neonatal Medicine, 2006
Pre-eclampsia is a common and potentially dangerous disorder of human pregnancy. The maternal syndrome of hypertension, proteinuria and oedema is part of a severe systemic inflammatory response that includes leukocyte and endothelial cell activation.
Borzychowski, A, Sargent, I, Redman, C
openaire   +3 more sources